Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
Biochemistry
|
January 31, 1995
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance
Y Lin, X Lin, L Hong, et al.
Biochemistry
|
September 8, 1992
X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors
J Cooper, W Quail, C Frazao, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1988
Aspartic proteinases and inhibitors for their control in health and disease
J Kay, R A Jupp, C G Norey, et al.
Protein Science : a Publication of the Protein Society
|
November 25, 1998
Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV
J Kervinen, J Lubkowski, A Zdanov, et al.
Biochemistry
|
June 9, 1992
Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites
J T Griffiths, L H Phylip, J Konvalinka, et al.
The Journal of Infectious Diseases
|
February 15, 2001
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients
E E Perez, S L Rose, B Peyser, et al.
Journal of Medicinal Chemistry
|
September 3, 1993
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation
C M Rao, P E Scarborough, J Kay, et al.
The Journal of Biological Chemistry
|
May 15, 1990
Sensitive, soluble chromogenic substrates for HIV-1 proteinase
A D Richards, L H Phylip, W G Farmerie, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1991
Substrate cleavage by HIV-1 proteinase
R A Jupp, A D Richards, L H Phylip, et al.
The Journal of Biological Chemistry
|
October 24, 2000
The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiae
L H Phylip, W E Lees, B G Brownsey, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
Biochemistry
|
January 31, 1995
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance
Y Lin, X Lin, L Hong, et al.
Biochemistry
|
September 8, 1992
X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors
J Cooper, W Quail, C Frazao, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1988
Aspartic proteinases and inhibitors for their control in health and disease
J Kay, R A Jupp, C G Norey, et al.
Protein Science : a Publication of the Protein Society
|
November 25, 1998
Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV
J Kervinen, J Lubkowski, A Zdanov, et al.
Biochemistry
|
June 9, 1992
Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites
J T Griffiths, L H Phylip, J Konvalinka, et al.
The Journal of Infectious Diseases
|
February 15, 2001
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients
E E Perez, S L Rose, B Peyser, et al.
Journal of Medicinal Chemistry
|
September 3, 1993
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation
C M Rao, P E Scarborough, J Kay, et al.
The Journal of Biological Chemistry
|
May 15, 1990
Sensitive, soluble chromogenic substrates for HIV-1 proteinase
A D Richards, L H Phylip, W G Farmerie, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1991
Substrate cleavage by HIV-1 proteinase
R A Jupp, A D Richards, L H Phylip, et al.
The Journal of Biological Chemistry
|
October 24, 2000
The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiae
L H Phylip, W E Lees, B G Brownsey, et al.
Page
of 13